marketcap
Facebook
Twitter
Telegram
Report an ErrorGW Pharmaceuticals plc Financial Ratios 2011-2024 | GWPH
Annual Financial Ratios GW Pharmaceuticals plc
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-82.3 | -4649.0 | -12.4 | -15.2 | -31.8 | -24.0 | -51.9 | -52.7 | - | - |
P/S |
9.1 | 134.7 | 288.2 | 243.3 | 196.3 | 37.5 | 25.3 | 8.8 | - | - |
EV/EBITDA |
-110.2 | -379.2 | -11.9 | -12.4 | -15.2 | -13.7 | -27.8 | -21.3 | - | - |
PEG |
-0.15 | 47.64 | -0.24 | -0.17 | -2.73 | -0.17 | -0.39 | 0.2 | - | - |
P/B |
6.5 | 57.8 | 8.8 | 7.2 | 5.1 | 4.4 | 4.8 | 6.8 | - | - |
P/CF |
-86.4 | -252.7 | -13.8 | -15.8 | -21.6 | -16.6 | -38.3 | -24.7 | - | - |
ROE % |
-7.84 | -1.24 | -71.10 | -47.34 | -15.97 | -18.17 | -9.24 | -12.85 | - | - |
ROA % |
-6.19 | -1.02 | -60.17 | -39.56 | -14.05 | -15.38 | -7.58 | -7.72 | - | - |
ROCE % |
-6.64 | -15.49 | -66.87 | -50.00 | -26.82 | -24.21 | -12.96 | -22.65 | - | - |
DSO |
49.3 | 57.3 | 60.8 | 1054.9 | 822.4 | 178.7 | 81.1 | 51.8 | - | - |
DIO |
1255.9 | 1147.8 | 1162.3 | 437.5 | 570.3 | 663.1 | 846.4 | 1333.3 | - | - |
DPO |
212.7 | 134.1 | 594.0 | 598.6 | 460.8 | 529.1 | 415.0 | 970.6 | - | - |
All numbers in USD currency